Cantitate/Preț
Produs

Therapeutic Ribonucleic Acids in Brain Tumors

Editat de Volker A. Erdmann, Guido Reifenberger, Jan Barciszewski
en Limba Engleză Paperback – 20 noi 2014
In the past few years nucleic acids technologies have grown into a powerful analytical and also increasingly therapeutic tool. It has been applied not only to the uncovering of gene functions in many organisms, but also to pathogenetic analysis and recently also for the treatment of human diseases. The book discusses in depth the potential of these innovative methods in the broad field of central nervous system and brain tumours particularly. Whereas there is currently no comprehensive overview on potential and challenges of nucleic acids technologies for basic brain tumours and for the clinical management of patients with brain tumours, this book does explicitly cover the many other aspects of the "RNA World" (pathogenic and therapeutic potential of microRNAs, aptamer technology, etc.), too. With this significantly broadened scope as compared to currently existing books it appears to be an urgently needed new publication.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 139741 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 20 noi 2014 139741 lei  6-8 săpt.
Hardback (1) 132675 lei  38-44 zile
  Springer Berlin, Heidelberg – sep 2009 132675 lei  38-44 zile

Preț: 139741 lei

Preț vechi: 147097 lei
-5% Nou

Puncte Express: 2096

Preț estimativ în valută:
26743 27861$ 22236£

Carte tipărită la comandă

Livrare economică 10-24 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642426285
ISBN-10: 364242628X
Pagini: 512
Ilustrații: XVI, 494 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.71 kg
Ediția:2009
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Descriere

In the past few years nucleic acids technologies have grown into a powerful analytical and also increasingly therapeutic tool. It has been applied not only to the uncovering of gene functions in many organisms, but also to pathogenetic analysis and recently also for the treatment of human diseases. The book discusses in depth the potential of these innovative methods in the broad field of central nervous system and brain tumours particularly. Whereas there is currently no comprehensive overview on potential and challenges of nucleic acids technologies for basic brain tumours and for the clinical management of patients with brain tumours, this book does explicitly cover the many other aspects of the "RNA World" (pathogenic and therapeutic potential of microRNAs, aptamer technology, etc.), too. With this significantly broadened scope as compared to currently existing books it appears to be an urgently needed new publication.

Cuprins

Introduction.- Molecular biology of malignant gliomas. Molecular noeurooncology and neoangiogenesis of malignant gliomas. Molecular therapies for malignant gliomas. Novel strategies for the treatment of brain cancer. Gene therapy for malignant glioma. Immunotherapeutic approach for glioma by alphaviruses as positive strand RNA viruses. Diagnosis of brain tumors through global specific DNA methylation . Molecular markers of gliomas. Microarray and proteomic analysis of Gliomas - Target strategies. Nanosystems for the delivery of RNAi. Interference RNA intervention in brain tumors. Blood-brain barrier transport of RNAi. Therapeutic potential of small interfering RNA for brain diseases. RNA interference (RNAi) based therapies against brain tumors: Potential clinical strategies. MicroRNA: Biogenesis, regulation, and role in primary brain tumors. Treatment of high-grade gliomas in adults. Treatment of malignant gliomas with antisense oligonucleotides. Suppression of EGFR expression by antisense RNA and RNAi. Brain tumor therapy with antisense oligonucleotides. Noncoding RNA in the development, function and pathologies of the central nervous system. The non-coding oncofetal H19 gene in brain tumors

Caracteristici

Includes supplementary material: sn.pub/extras